SCM
ADAP

Suvretta Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Suvretta Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-268,900
Closed -$2.69M – 93
2020
Q2 		$2.69M Buy
+268,900
New +$2.69M 0.06% 65